Biodesix Inc. Common Stock (BDSX)

Fundamentals

Market cap

$228.14M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

—

Biodesix Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BDSX

  Biodesix Inc. Common Stock

  $26.81

  ▼ 5.86%
  Market cap $228.14MP/E —
• ACH

  Accendra Health Inc. Common Stock

  $1.22

  ▲ 0.83%
  Market cap $261.15MP/E —
  $0.9337$5.69
• TLSI

  TriSalus Life Sciences Inc. Common Stock

  $4.85

  ▼ 1.62%
  Market cap $291.73MP/E —
  $2.2$7.95
• YDES

  YD Bio Limited Ordinary Shares

  $4.8

  ▲ 24.03%
  Market cap $162.91MP/E —
  $1.7$25
• KEQU

  Kewaunee Scientific Corporation Common Stock

  $37.78

  ▼ 0.50%
  Market cap $107.27MP/E 10.89
  $33.27$59
• BNR

  Burning Rock Biotech Limited American Depositary Shares

  $10.19

  ▲ 1.90%
  Market cap $93.65MP/E —
  $6.79$41.72
• SERA

  Sera Prognostics Inc. Class A Common Stock

  $2.07

  ▲ 0.49%
  Market cap $78.32MP/E —
  $1.56$3.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $35
  Benzinga · 8/10/2026
• HC Wainwright & Co. Maintains Buy on Biodesix, Raises Price Target to $27
  Benzinga · 8/6/2026
• Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip
  ChartMill · 8/5/2026
• Biodesix Affirms FY2026 Sales Guidance of $108.000M-$114.000M vs $110.996M Est
  Benzinga · 8/5/2026

• PATIENCE JOHN · June 30, 2026 · Option Exercise

  1.4K
• PATIENCE JOHN · March 31, 2026 · Option Exercise

  1.4K

Institutional Ownership

March 31, 2026

Total shares held

3.56M

Total value held

$50.82M

Institutional holders

37